550 related articles for article (PubMed ID: 33091416)
1. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
Hu J; Jolkkonen J; Zhao C
Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
[TBL] [Abstract][Full Text] [Related]
2. Update on neurological manifestations of COVID-19.
Yavarpour-Bali H; Ghasemi-Kasman M
Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
[TBL] [Abstract][Full Text] [Related]
3. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
4. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
5. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
Jagst M; Pottkämper L; Gömer A; Pitarokoili K; Steinmann E
Curr Opin Microbiol; 2024 Jun; 79():102474. PubMed ID: 38615394
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
[TBL] [Abstract][Full Text] [Related]
7. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
ElBini Dhouib I
Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 invasion of the central nervous: a brief review.
Siddiqui R; Mungroo MR; Khan NA
Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
[TBL] [Abstract][Full Text] [Related]
9. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
10. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.
Li FF; Zhang Q; Wang GY; Liu SL
Aging (Albany NY); 2020 Nov; 12(21):20938-20945. PubMed ID: 33186121
[TBL] [Abstract][Full Text] [Related]
13. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
14. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and its effects on neurological functions.
Yew MMT; Lip JQ; Ling APK
Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
[TBL] [Abstract][Full Text] [Related]
16. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
17. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Ahmadi S; Khaledi S
Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
[TBL] [Abstract][Full Text] [Related]
18. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
19. Binding and entering: COVID finds a new home.
Vu MN; Menachery VD
PLoS Pathog; 2021 Aug; 17(8):e1009857. PubMed ID: 34460863
[TBL] [Abstract][Full Text] [Related]
20. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.
Rodriguez M; Soler Y; Perry M; Reynolds JL; El-Hage N
Front Neurol; 2020; 11():583459. PubMed ID: 33304309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]